Examkin

Soru

Zorluk: KolayPharmacologic Interventions

A 68-year-old woman presents to the outpatient clinic reporting a burning sensation during urination and increased urinary frequency for the past 3 days. She reports no fever, chills, flank pain, or vaginal discharge. Her medical history is significant for atrial fibrillation, for which she takes warfarin, and stage 4 chronic kidney disease. Her current medications include warfarin, metoprolol, and a daily multivitamin. Vital signs are within normal limits. Physical examination reveals mild suprapubic tenderness but no costovertebral angle tenderness.

Laboratory results:
TestResult
Serum creatinine2.4 mg/dL
Estimated GFR22 mL/min/1.73 m²
INR2.6
Urinalysis:
TestResult
AppearanceCloudy
Leukocyte esterasePositive
NitritesPositive
BloodTrace

Which of the following is the most appropriate pharmacologic intervention for this patient's current condition?

  1. CephalexinCevap
  2. B
    Nitrofurantoin
  3. C
    Trimethoprim-sulfamethoxazole
  4. D
    Ampicillin
  5. E
    Phenazopyridine monotherapy

Cevap

Cephalexin is the most appropriate pharmacologic intervention because it treats the infection safely without interacting with warfarin or being contraindicated by the patient's severe chronic kidney disease.
Cephalexin is a safe and effective empiric choice for uncomplicated cystitis in this patient. It provides adequate coverage for common urinary pathogens, can be used safely in severe chronic kidney disease (with appropriate dose adjustment), and does not have significant drug-drug interactions with warfarin.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical presentation and urinalysis.
The patient has uncomplicated cystitis, indicated by dysuria, frequency, and a urinalysis positive for leukocyte esterase and nitrites.
Establishing the correct infectious diagnosis determines the need for antimicrobial therapy.
2
Evaluate the patient's comorbidities and current medications to identify contraindications.
The patient has stage 4 chronic kidney disease (eGFR 22 mL/min/1.73 m²) and is taking warfarin for atrial fibrillation.
Renal impairment and concurrent anticoagulant use heavily restrict the choice of safe antimicrobial agents.
3
Select an antibiotic that is safe and effective given the patient's specific constraints.
Cephalexin is chosen because it does not interact with warfarin and achieves adequate urinary concentrations in severe chronic kidney disease.
First-line agents like nitrofurantoin and trimethoprim-sulfamethoxazole must be avoided due to the patient's severe renal impairment and concurrent warfarin use, respectively.

Anahtar Kavram

Selection of appropriate antimicrobial therapy for uncomplicated cystitis in the setting of severe chronic kidney disease and concurrent warfarin use.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru